.

Connect Planning and Performance to drive true S&OP/IBP success in Pharma and Life Science businesses.

Frankfurt, Germany - In today’s complex Pharma and Life Science environment, aligning strategy, finance, and operations is critical to ensuring resilient, patient-centric supply chains. Sales & Operations Planning (S&OP) and Integrated Business Planning (IBP) have become essential tools to break silos, improve forecast accuracy, and drive enterprise-wide agility. Yet, many organizations struggle to bridge the gap between tactical execution and strategic alignment.

The Pharma and Life Science industry is at a critical inflection point: geopolitical disruptions, rising portfolio complexity, regulatory pressures, and market volatility are putting unprecedented strain on supply chains and planning functions. At the same time, advances in analytics, AI, and integrated planning tools are unlocking new opportunities for transformation. Now is the moment for leaders to strengthen collaboration across finance, supply chain, and commercial functions to drive resilience, agility, and sustainable growth.

The Marcus Evans S&OP and IBP for Pharma & Life Science conference taking place, in Frankfurt, Germany, will bring together senior leaders in supply chain, finance, and planning to explore how pharmaceutical and life sciences organizations are transforming S&OP/IBP to accelerate decision-making, enhance planning accuracy, and strengthen business alignment.

Building on the momentum of previous Marcus Evans S&OP conferences, this event goes deeper into the distinct challenges of regulated, patient-centric environments — from managing clinical pipelines and navigating global compliance to handling portfolio complexity and forecasting rare diseases. Participants will gain value from tailored case studies, structured maturity frameworks, and targeted networking with peers who share similar industry-specific hurdles. This refined focus ensures practical, actionable insights that move beyond general principles and directly address the realities of planning in Pharma and Life Sciences.

Key Topics Include:

• Transform S&OP into IBP to Connect Strategy, Finance, and Execution

• Cross Functional Collaboration – Key for Successful S&OP/IBP

• Balance Short- and Long-Term Planning to Enable Strategic Alignment

• Leverage AI and Data to Strengthen S&OP and IBP Foundations

• Drive Change Management to Advance S&OP and IBP Maturity

• Align Portfolio and Demand to Build a Single Planning Narrative

Best Practices and Case Studies from:

• Anastasia Dorizon, Head of IBP Governance and Implementation, Merck Life Science, Switzerland

• Tatjana Sretenovic-Rajicic, Head Global Demand Planning - Rare Disease, Bayer, Netherlands

• Claudia Lynn Martínez, Associate Director, New Product Planning and Portfolio Strategy (Food Allergy Therapy Area), Sanofi, Spain

• Flavia Rodrigues, Director Supply Chain Planning and Analytics, Bristol Myers Squibb, Switzerland

• Laura Santi, Head of Integrated Business Planning, Ipsen, France

• Agnieszka Romaniuk, Vice President Supply Chain, Thermo Fisher Scientific, Netherlands

Healthcare Business Review members are entitled to €200 discount! For more information please contact: Ria Kiayia, Marketing Manager, Digital Media and PR at riak@marcusevanscy.com or visit: https://tinyurl.com/4jpwey36